Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice

Shin-ichiro Nakagawa1, Takuya Umehara, Chiho Matsuda

  • 1Department of Microbiology and Cell Biology, The Tokyo Metropolitan Institute of Medical Science, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8613, Japan.

Insights

Inhibiting heat shock protein 90 (Hsp90) effectively suppresses hepatitis C virus (HCV) replication. Targeting Hsp90 offers a promising new therapeutic strategy for treating HCV infections.

Area of Science:

  • Hepatology
  • Virology
  • Molecular Biology

Background:

  • Persistent hepatitis C virus (HCV) infection leads to severe liver diseases, including cirrhosis and cancer.
  • Current treatments for HCV can be limited by efficacy and side effects.

Purpose of the Study:

  • To investigate the role of heat shock protein 90 (Hsp90) in HCV replication.
  • To evaluate the therapeutic potential of Hsp90 inhibition for HCV infection.

Main Methods:

  • Utilized HCV replicon cell systems to assess the impact of Hsp90 inhibitors and siRNA-mediated knockdown on viral replication.
  • Examined the effect of Hsp90 inhibition in HCV-infected chimeric mice with humanized livers.
  • Compared the efficacy of Hsp90 inhibitor combined with pegylated interferon (PEG-IFN) against PEG-IFN monotherapy.

Main Results:

  • Hsp90 inhibitors and Hsp90 knockdown significantly reduced HCV genome replication in cell-based assays.
  • The suppressive effect of Hsp90 inhibitors on HCV replication was reversed by Hsp90 expression.
  • Combination therapy with an Hsp90 inhibitor and PEG-IFN demonstrated superior reduction of serum HCV RNA levels compared to PEG-IFN alone in vivo.

Conclusions:

  • Heat shock protein 90 plays a crucial role in supporting HCV replication.
  • Inhibition of Hsp90 presents a novel and effective therapeutic strategy for managing HCV infections.
  • Combined Hsp90 inhibition and PEG-IFN therapy may offer an enhanced treatment approach for hepatitis C.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...